Details
Stereochemistry | ACHIRAL |
Molecular Formula | C8H8O3 |
Molecular Weight | 152.1473 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC(C=O)=CC=C1O
InChI
InChIKey=MWOOGOJBHIARFG-UHFFFAOYSA-N
InChI=1S/C8H8O3/c1-11-8-4-6(5-9)2-3-7(8)10/h2-5,10H,1H3
Molecular Formula | C8H8O3 |
Molecular Weight | 152.1473 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Vanillin (4-hydroxy-3-methoxybenzaldehyde), a pleasant smelling organic aromatic compound, is widely used as a flavoring additive in food, beverage, cosmetic and drug industries. It is reported to cross the blood brain barrier and also displayed antioxidant and neuroprotective activities. Vanillin is a natural substance widely found in many plant species and often used in beverages, foods, cosmetics, and pharmaceutical products. Antioxidant and anticancer potential have been described for this compound. Vanillin has been classified as
a bioantimutagen and is able to inhibit mutagenesis induced
by chemical and physical mutagens in various cell systems. Vanillin, a selective agonist of TRPV1, has been shown to attenuate i.c.v. STZ and AlCl3+d-galactose induced experimental Alzheime's disease (AD).
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP408 Sources: https://www.ncbi.nlm.nih.gov/pubmed/28077989 |
16.25 µM [IC50] | ||
Target ID: CHEMBL4357 Sources: https://www.ncbi.nlm.nih.gov/pubmed/25674660 |
81.5 µM [IC50] | ||
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23715789 |
0.037 mM [IC50] | ||
Target ID: CHEMBL1781864 Sources: https://www.ncbi.nlm.nih.gov/pubmed/27084583 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
no | ||||
no | ||||
no | ||||
no | ||||
no | ||||
yes | ||||
yes |
Drug as victim
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
no | ||||
no | ||||
no | ||||
yes | ||||
yes | ||||
yes | ||||
yes | ||||
yes | ||||
yes | ||||
yes | ||||
yes | ||||
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Changes in low molecular weight phenolic compounds in Spanish, French, and American oak woods during natural seasoning and toasting. | 2001 Apr |
|
Human potency predictions for aldehydes using the local lymph node assay. | 2001 Aug |
|
Aroma-active components of nonfat dry milk. | 2001 Jun |
|
Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. | 2001 Mar |
|
Antioxidant activity of resveratrol compared with common food additives. | 2001 Mar |
|
Changes in the phenolic composition of virgin olive oil from young trees (Olea europaea L. cv. Arbequina) grown under linear irrigation strategies. | 2001 Nov |
|
The coenzyme A-dependent, non-beta-oxidation pathway and not direct deacetylation is the major route for ferulic acid degradation in Delftia acidovorans. | 2001 Nov 27 |
|
Free radical scavenging activity of vanillin and o-vanillin using 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical. | 2002 |
|
Conservation and diversity of gene families explored using the CODEHOP strategy in higher plants. | 2002 Aug 1 |
|
Asymmetry of pleasant vs. unpleasant odor processing during affective judgment in humans. | 2002 Aug 16 |
|
Chromone and phenanthrene alkaloids from Dennettia tripetala. | 2002 Dec |
|
Colorimetric and fluorimetric methods for determination of panthenol in cosmetic and pharmaceutical formulation. | 2002 Feb 1 |
|
Volatile components of Loureira, Dona Branca, and Treixadura wines. | 2002 Jan 30 |
|
A biotechnological process involving filamentous fungi to produce natural crystalline vanillin from maize bran. | 2002 Jul-Dec |
|
Determination of available phenolic compounds in soils by liquid chromatography with solid-phase extraction. | 2002 Nov-Dec |
|
Quantitation of odor-active compounds in rye flour and rye sourdough using stable isotope dilution assays. | 2002 Sep 11 |
|
Changes in the HPLC phenolic profile of virgin olive oil from young trees (Olea europaea L. Cv. Arbequina) grown under different deficit irrigation strategies. | 2002 Sep 11 |
|
A novel strategy for the synthesis of benzofuran skeleton neolignans: application to ailanthoidol, XH-14, and obovaten. | 2002 Sep 20 |
|
Probing suggested catalytic domains of glycosyltransferases by site-directed mutagenesis. | 2003 Feb |
|
Colorimetric determination of gabapentin in pharmaceutical formulation. | 2003 Feb 5 |
|
Photo-Fenton treatment of water containing natural phenolic pollutants. | 2003 Jan |
|
Potential inhibitors from wet oxidation of wheat straw and their effect on ethanol production of Saccharomyces cerevisiae: wet oxidation and fermentation by yeast. | 2003 Mar 20 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28077989
Mice: In in vivo antioxidant assay, mice were orally given a
single dose (100 mg/kg) of vanillin. The highest activity in
the plasma ORAC assay was observed at 5 min, when the
concentrations of vanillin, vanillic acid, and protocatechuic
acid were high.
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/28077989
Vanillin at 2.5 mM
inhibited protein oxidation and lipid peroxidation induced by
photosensitization with methylene blue plus light in rat liver
mitochondria. It also exhibited hydroxyl radical and
2,2`-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) radical
cation (ABTS∙+) (IC50 value of 16.25 uM) scavenging
activities. Pretreatment of vanillin (100 nM) also reduced rotenone
induced mitochondrial dysfunction, oxidative stress, and
apoptosis in SH-SY5Y neuroblastoma cells
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 13:29:58 GMT 2025
by
admin
on
Wed Apr 02 13:29:58 GMT 2025
|
Record UNII |
CHI530446X
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EPA PESTICIDE CODE |
115801
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
||
|
EC SCIENTIFIC COMMITTEE ON CONSUMER SAFETY OPINION |
SCCS/1459/11
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
||
|
JECFA EVALUATION |
VANILLIN
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DTXSID0021969
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
C45678
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
CONCEPT | Industrial Aid | ||
|
m11390
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | Merck Index | ||
|
1711009
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
ALTERNATIVE | |||
|
819
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
100000076965
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
1027
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
SUB15686MIG
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
C100058
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
403658
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
CHI530446X
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
48383
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
CHI530446X
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
121-33-5
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
1710006
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
1368176
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | RxNorm | ||
|
15351
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
1183
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
204-465-2
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
VANILLIN
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
C76737
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
CHEMBL13883
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY | |||
|
18346
Created by
admin on Wed Apr 02 13:29:58 GMT 2025 , Edited by admin on Wed Apr 02 13:29:58 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> METABOLITE |
MINOR
PLASMA
|